Item 8.01. Other Events.
On March 1, 2021, Isleworth Healthcare Acquisition Corp. (the "Company")
consummated its initial public offering ("IPO") of 18,000,000 units (the
"Units"). Each Unit consists of one share of common stock of the Company, par
value $0.0001 per share, and one-half of one redeemable warrant of the Company
("Warrant"). Each Warrant entitles the holder thereof to purchase one share of
common stock for $11.50 per share, subject to adjustment. The Units were sold at
a price of $10.00 per Unit, generating gross proceeds to the Company of
$180,000,000. Simultaneously with the closing of the IPO, pursuant to certain
Warrant Purchase Agreements, the Company completed the private sale of an
aggregate of 5,600,000 warrants (the "Private Placement Warrants") to Isleworth
Healthcare Sponsor I, LLC and I-Bankers Securities, Inc. at a purchase price of
$1.00 per Private Placement Warrant, generating gross proceeds to the Company of
$5,600,000.
In connection with the IPO, the underwriters were granted a 30-day option from
the date of the prospectus to purchase up to 2,700,000 additional units to cover
over-allotment, if any. On March 2, 2021, the underwriters fully exercised the
over-allotment option. The units were sold at an offering price of $10.00 per
Unit, generating additional gross proceeds of $27,000,000 to the Company.
Simultaneously with the closing of the over-allotment option, pursuant to
certain Warrant Purchase Agreements, the Company completed the private sale of
an aggregate of an additional 540,000 Private Placement Warrants to Isleworth
Healthcare Sponsor I, LLC and I-Bankers Securities, Inc. at a purchase price of
$1.00 per Private Placement Warrant, generating gross proceeds to the Company of
$540,000.
A total of $207,000,000 of the proceeds from the IPO (including the full
exercise of the over-allotment option) and the sale of the Private Placement
Warrants were placed in a U.S.-based trust account maintained by Continental
Stock Transfer & Trust Company, acting as trustee.
An audited balance sheet as of March 1, 2021 reflecting receipt of the proceeds
upon consummation of the IPO and the issuance of the Private Placement Warrants
has been issued by the Company and is included as Exhibit 99.1 to this Current
Report on Form 8-K, and a unaudited pro-forma balance sheet reflecting the
exercise of the over-allotment option on March 2, 2021 is included as Exhibit
99.2 to this Current Report.
© Edgar Online, source Glimpses
ISLEWORTH HEALTHCARE ACQUISITION CORP. 
